OCC

2.78%

37.0¢

ORTHOCELL LIMITED

Market Cap $77.45M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Latest Threads

Tag

Subject

OCC

Media thread

7 8 9

14:08

535

169K

14:08

Last post simons77

535

169K

OCC

Ann: Third Revenue Generating Product to be Launched in SmrtGraft

17/06/24

4.6K

17/06/24

Last post Valueformoney

4.6K

OCC

Ann: Proposed issue of securities - OCC

13/06/24

3.4K

13/06/24

Last post Speckled

3.4K

OCC

Ann: Notification regarding unquoted securities - OCC

12/06/24

297

12/06/24

Last post

ASX News

297

OCC

News: OCC Orthocell Applies For Australian Market Approval For Smrtgraft Tendon Repair Device

11/06/24

143

11/06/24

Last post

Hot News

143

OCC

Ann: Remplir Expansion Continues with Singapore Application

07/06/24

7.1K

07/06/24

Last post scolloymore

7.1K

OCC

OCC Trading

27 28 29

07/06/24

1.6K

491K

07/06/24

Last post bedger

1.6K

491K

OCC

Ann: Notification of cessation of securities - OCC

05/06/24

340

05/06/24

Last post

ASX News

340

See All Discussions

Timeline

Notification regarding unquoted securities - OCC
12 Jun 08:24	Share

Proposed issue of securities - OCC
11 Jun 15:58	Share

Third Revenue Generating Product to be Launched in SmrtGraft
11 Jun 08:56	Share

Notification of cessation of securities - OCC
05 Jun 08:26	Share

Outstanding 98.6% Success Rate in Striate Implant Study
14 May 09:05	Share

Compelling 85% Success Rate Remplir Study now published
30 Apr 09:49	Share

Change of Director's Interest Notice-John Van Der Wielen
24 Apr 11:52	Share

Securities Trading Policy
24 Apr 11:23	Share

Change of Director's Interest Notice-John Van Der Wielen
16 Apr 08:56	Share

Orthocell receives $3.05m R&D tax incentive refund
15 Apr 09:03	Share

Quarterly Activity Report & Appendix 4C
08 Apr 09:03	Share

Part 1 Remplir US Market Authorisation Successfully Complete
25 Mar 09:19	Share

Cleansing Notice
11 Mar 18:06	Share

Application for quotation of securities - OCC
11 Mar 18:05	Share

Application for quotation of securities - OCC
11 Mar 18:04	Share

Cleansing Notice
28 Feb 10:27	Share

Application for quotation of securities - OCC
28 Feb 10:24	Share

Appendix 4D & Half-Year Financial Statements
23 Feb 15:27	Share

Proposed issue of securities - OCC
22 Feb 09:20	Share

Strategic Placement to Raise $3.5 million
22 Feb 09:20	Share

Trading Halt
20 Feb 09:43	Share

Remplir Expansion Continues with Singapore Application
13 Feb 09:14	Share

Notification of cessation of securities - OCC
06 Feb 08:15	Share

Quarterly Activity Report & Appendix 4C
29 Jan 08:57	Share

Appendix 3Y - Kim Beazley
17 Jan 14:14	Share

Notification regarding unquoted securities - OCC
17 Jan 14:11	Share

Final Director's Interest Notice
16 Jan 09:15	Share

Orthocell Board Changes
15 Jan 16:50	Share

Initial Director's Interest Notice - Mr Kim Beazley
15 Jan 11:05	Share

Proposed issue of securities - OCC
15 Jan 09:18	Share

View More

(20min delay)
Last 37.0¢		Change 0.010(2.78%)		Mkt cap ! $77.45M

Open	High	Low	Value	Volume
36.5¢	37.0¢	36.0¢	$96.07K	263.3K

Buyers (Bids)

No.	Vol.	Price($)
3	19500	36.5¢

Sellers (Offers)

Price($)	Vol.	No.
37.0¢	98323	1

View Market Depth

No.	Vol.	Price($)
3	19500	0.365
4	90348	0.360
6	33009	0.355
5	49067	0.350
3	80000	0.345

Price($)	Vol.	No.
0.370	108323	1
0.375	4000	1
0.380	26345	2
0.385	72893	2
0.390	13002	4

Last trade - 15.29pm 18/06/2024 (20 minute delay)


Last 36.0¢		Change 0.010 ( 0.00 %)
Open	High	Low	Volume
36.5¢	37.0¢	36.0¢	41148
Last updated 13.10pm 18/06/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED

Latest Threads

Sun Silver's 6,216g/t silver (Ag) intercept within a high-grade target zone

Timeline

Featured News

Latest Articles

Orthocell's Remplir shows 85% success rate in nerve repair study

Orthocell's medical device RemplirTM shows 85% success rate in latest nerve repair study, holding a promise for millions of individuals

Orthocell (ASX:OCC) launches fresh rat nerve-repair study

Regenerative medicine company Orthocell (ASX:OCC) has begun a 'comparator' study as part of its pre-clinical and clinical development program in nerve repair and regeneration.

Orthocell (ASX:OCC) bolsters medical scientific advisory board with US-based nerve surgeons

Orthocell (ASX:OCC) has appointed US-based nerve surgeons Professor Christopher Dy and Professor David Brogan to its medical scientific advisory board.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News